Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Chugai Pharmaceutical Co. Ltd.
CHGCYCurrent price
24.22 USD
-0.22 USD (-0.90%)
Last closed
6 848 JPY
Company
www.chugai-pharm.co.jp
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
TSE
Capitalization
11 863 312 459 766 JPY
Yield for 12 month
+67.74 %
1Y
3Y
5Y
10Y
15Y
CHGCY
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng. It has various development product candidates in the areas of oncology, immunology, neuroscience, hematology, ophthalmology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances and collaboration with Roche Group. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding Ltd. Address: 2-1-1 Nihonbashi-Muromachi, Chuo, Japan, 103-8324
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
880 914.46 JPYP/E ratio
33.5868Dividend Yield
1.2 %Current Year
+1 105 949 091 761 JPY
Last Year
+1 253 803 769 887 JPY
Current Quarter
+314 370 935 570 JPY
Last Quarter
+235 793 874 893 JPY
Current Year
+689 630 584 754 JPY
Last Year
+779 874 491 082 JPY
Current Quarter
+226 859 642 637 JPY
Last Quarter
+163 199 505 740 JPY
Key Figures CHGCY
1 year
3 years
5 years
10 years
EBITDA
515 573 279 616 JPY
Operating Margin TTM
PE Ratio
33.5868
Return On Assets TTM
15.63 %
PEG Ratio
6.4552
Return On Equity TTM
21.75 %
Wall Street Target Price
880 914.46 JPY
Revenue TTM
1 079 282 736 548 JPY
Book Value
1 059.36 JPY
Revenue Per Share TTM
Dividend Share
39.81 JPY
Quarterly Revenue Growth YOY
18.1 %
Dividend Yield
1.2 %
Gross Profit TTM
779 874 491 026 JPY
Earnings per share
214.66 JPY
Diluted Eps TTM
214.66 JPY
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
34.5 %
Profit Margin
32.74 %
Dividend Analytics CHGCY
Dividend growth over 5 years
433 %Continuous growth
2 yearsPayout Ratio 5 years average
44 %Dividend History CHGCY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
82
Ex Dividend Date
27.12.2024
Forward Annual Dividend Yield
1.2 %
Last Split Factor
3:1
Payout Ratio
37.54 %
Last Split Date
29.06.2020
Dividend Date
–
Stock Valuation CHGCY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
33.5868
Forward PE
30.4878
Enterprise Value Revenue
9.6375
Price Sales TTM
10.9918
Enterprise Value EBITDA
21.4026
Price Book MRQ
6.4327
Financials CHGCY
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CHGCY
For 52 weeks
4 116.27 JPY
7 212.67 JPY
50 Day MA
5 927.3 JPY
Shares Short Prior Month
–
200 Day MA
5 478.85 JPY
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart